Vasopressin deficiency: driver of social impairment and fluid imbalance in ASD? [pdf]
Emerging research on vasopressin (also known as antidiuretic hormone) suggests that deficiencies in this hormone may contribute both to social impairment and to abnormal thirst and urination in some autistic people, potentially linking autism with conditions like central diabetes insipidus and certain blood-pressure or fluid-balance disorders. Commenters explore what this might mean for diagnosis and treatment — from copeptin testing and desmopressin or vasopressin-based therapies to parallels with other biochemical approaches such as SSRIs and anti-inflammatory diets — while emphasizing that evidence is still early and often mixed. More speculative ideas, such as tying autism trends to indoor CO₂ levels via vasopressin, are met with strong skepticism and calls for rigorous physiological explanations.
Role of Vasopressin (AVP) in ASD and Comorbid Conditions
- Several commenters interpret the paper as proposing that low central vasopressin contributes to autistic social symptoms.
- Based on that, people expect higher rates of AVP-related conditions in autistic individuals, especially central diabetes insipidus (excessive thirst/urination), rather than a direct ASD–hypertension link.
- There is confusion about whether AVP’s vasoconstrictive, blood-pressure-regulating role means salt or blood pressure changes could “treat” ASD; replies stress this is not what the paper claims.
- One anecdote: long-term extreme salt avoidance in an autistic person did not change ASD traits or blood pressure but led to other health issues.
- Discussion notes a U-shaped relationship for salt and fat intake (too little and too much both harmful), and tangential debate over low-salt, low-fat, keto, and cardiovascular risk.
Diagnostics and Potential Treatments
- Commenters mention copeptin testing as a proxy for AVP in autistic individuals with high fluid intake.
- Desmopressin and diabetes insipidus protocols are suggested as reference points for potential management, but concrete ASD-specific treatment paths are unclear.
- Links to clinical trials: one AVP-pathway drug reportedly did nothing for a participant and the study was cancelled; another small trial suggested AVP might reduce social impairment in some children.
Physiology, Naming, and Complexity
- The dual naming (AVP/ADH) is seen as obscuring the hormone’s multiple roles.
- Broader point: neuropsychiatric conditions (ASD, depression, etc.) are ultimately biochemical; “antidepressants” are used as an example of drugs misnamed by first indication rather than mechanism.
Anecdotes and Curious Phenomena
- Reports that fever can temporarily reduce autistic traits in some, supported by a cited mouse/clinical-observation article.
- Sleep deprivation described as transiently improving depression for some.
- Individual accounts: SSRI-induced hypertensive crisis with excessive urination in a person with ASD; interest in whole-genome sequencing and serotonin-related variants; suggestion of possible serotonin syndrome.
- Observations of “ruddiness/doughiness” in some autistic people are speculatively linked to fluid imbalance.
Air Quality, CO₂, and Speculative Theories
- One commenter claims vasopressin is tied to elevated indoor CO₂ and suggests modern indoor lifestyles and poor ventilation may contribute to “novel social conditions” and ASD rates.
- Others strongly challenge this:
- Point out complex feedback loops in physiology that make a simple CO₂→vasopressin→ASD model unlikely.
- Note lack of evidence and caution against adding to the burden of pseudoscientific claims around autism.
- Debate whether dense urban housing vs. ventilation practices drive indoor CO₂, and whether cars or ambient city CO₂ are relevant.
- CO₂ measurements on planes are mentioned, but instrument reliability and interpretation are questioned.
- The direction of effect is also clarified: the article discusses vasopressin deficiency, so CO₂-induced increases would not straightforwardly match that mechanism.
Information Trust and Scientific Literacy
- Commenters lament the lack of a systematic, trustworthy, easily navigable synthesis of medical evidence.
- There is debate over who should bear responsibility for judging trustworthiness (individual vs. institutions) and whether industry influence (e.g., sugar vs. fat debates) has distorted “expert” advice.
- Some argue that individuals must cultivate critical thinking; others emphasize the difficulty given misinformation, conflicts of interest, and emergent AI-generated content.
Autism Prevalence and Diagnosis Trends
- One thread attributes rising ASD diagnoses partly to more time indoors and less outdoor activity; others counter that diagnostic criteria, awareness, parental age, and social attitudes have changed.
- Historical analogies are made: left-handedness and homosexuality were once pathologized; when stigma declined, reported prevalence increased without clear evidence of a true rate change.
- Multiple commenters stress that correlation (e.g., with lifestyle or urbanization) does not imply causation and that many prior generations of autistic children were mislabeled or mistreated under other categories.